Cardiol Therapeutics Inc. – NASDAQ:CRDL

Cardiol Therapeutics stock price today

$1.14
-0.17
-12.98%
Financial Health
0
1
2
3
4
5
6
7
8
9

Cardiol Therapeutics stock price monthly change

-38.50%
month

Cardiol Therapeutics stock price quarterly change

-38.50%
quarter

Cardiol Therapeutics stock price yearly change

+57.60%
year

Cardiol Therapeutics key metrics

Market Cap
104.04M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-0.47
Revenue
N/A
EBITDA
-29.52M
Income
-30.21M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Cardiol Therapeutics stock price history

Cardiol Therapeutics stock forecast

Cardiol Therapeutics financial statements

Cardiol Therapeutics Inc. (NASDAQ:CRDL): Profit margin
Jun 2023 0 -7.47M
Sep 2023 0 -5.93M
Dec 2023 0 -7.63M
Mar 2024 0 -9.17M
Cardiol Therapeutics Inc. (NASDAQ:CRDL): Analyst Estimates
Sep 2025 0 -6.38M
Dec 2025 0 -5.39M
Mar 2026 0 -5.39M
Jun 2026 0 -6.38M
  • Analysts Price target

  • Financials & Ratios estimates

Cardiol Therapeutics Inc. (NASDAQ:CRDL): Debt to assets
Jun 2023 47169272 8.41M 17.85%
Sep 2023 43053024 8.18M 19.01%
Dec 2023 36700508 8.45M 23.04%
Mar 2024 31126280 11.06M 35.56%
Cardiol Therapeutics Inc. (NASDAQ:CRDL): Cash Flow
Jun 2023 -5.35M -3.89K -13.84K
Sep 2023 -3.41M -5.57K -13.84K
Dec 2023 -6.46M -10.70K -13.84K
Mar 2024 -6.92M -3.46K 76.35K

Cardiol Therapeutics alternative data

Cardiol Therapeutics Inc. (NASDAQ:CRDL): Employee count
Mar 2024 22
Apr 2024 22
May 2024 22
Jun 2024 22
Jul 2024 22

Cardiol Therapeutics other data

10.87% -4.74%
of CRDL is owned by hedge funds
6.79M +47.15K
shares is hold by hedge funds
Thursday, 19 December 2024
globenewswire.com
Friday, 29 November 2024
marketbeat.com
Monday, 18 November 2024
proactiveinvestors.com
newsfilecorp.com
Wednesday, 13 November 2024
globenewswire.com
prismmediawire.com
Thursday, 27 June 2024
newsfilecorp.com
Tuesday, 25 June 2024
newsfilecorp.com
Thursday, 13 June 2024
proactiveinvestors.com
newsfilecorp.com
Friday, 24 May 2024
zacks.com
Tuesday, 14 May 2024
InvestorPlace
Proactive Investors
Tuesday, 2 April 2024
Proactive Investors
Proactive Investors
Wednesday, 21 February 2024
Proactive Investors
Friday, 16 February 2024
Proactive Investors
Thursday, 15 February 2024
Proactive Investors
Tuesday, 9 January 2024
Proactive Investors
Tuesday, 5 December 2023
Proactive Investors
Thursday, 16 November 2023
Proactive Investors
Wednesday, 1 November 2023
Proactive Investors
Tuesday, 10 October 2023
Proactive Investors
Wednesday, 27 September 2023
Zacks Investment Research
Tuesday, 26 September 2023
Newsfile Corp
Tuesday, 19 September 2023
Zacks Investment Research
Proactive Investors
Monday, 18 September 2023
Zacks Investment Research
Wednesday, 16 August 2023
Zacks Investment Research
Wednesday, 9 August 2023
Newsfile Corp
  • What's the price of Cardiol Therapeutics stock today?

    One share of Cardiol Therapeutics stock can currently be purchased for approximately $1.14.

  • When is Cardiol Therapeutics's next earnings date?

    Unfortunately, Cardiol Therapeutics's (CRDL) next earnings date is currently unknown.

  • Does Cardiol Therapeutics pay dividends?

    No, Cardiol Therapeutics does not pay dividends.

  • How much money does Cardiol Therapeutics make?

    Cardiol Therapeutics has a market capitalization of 104.04M.

  • What is Cardiol Therapeutics's stock symbol?

    Cardiol Therapeutics Inc. is traded on the NASDAQ under the ticker symbol "CRDL".

  • What is Cardiol Therapeutics's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Cardiol Therapeutics?

    Shares of Cardiol Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Cardiol Therapeutics have?

    As Jul 2024, Cardiol Therapeutics employs 22 workers.

  • When Cardiol Therapeutics went public?

    Cardiol Therapeutics Inc. is publicly traded company for more then 6 years since IPO on 15 Jan 2019.

  • What is Cardiol Therapeutics's official website?

    The official website for Cardiol Therapeutics is cardiolrx.com.

  • Where are Cardiol Therapeutics's headquarters?

    Cardiol Therapeutics is headquartered at 2265 Upper Middle Road East, Oakville, ON.

  • How can i contact Cardiol Therapeutics?

    Cardiol Therapeutics's mailing address is 2265 Upper Middle Road East, Oakville, ON and company can be reached via phone at 289 910 0850.

Cardiol Therapeutics company profile:

Cardiol Therapeutics Inc.

cardiolrx.com
Exchange:

NASDAQ

Full time employees:

22

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

2265 Upper Middle Road East
Oakville, ON L6H 0G5

CIK: 0001702123
ISIN: CA14161Y2006
CUSIP: 14161Y200